Serum Institute
-
Serum Institute 'hopeful' of producing Mpox vaccine, says CEO Adar Poonawalla
India | Aug 21, 2024, 08:46 AM ISTThe Serum Institute of India is working on a vaccine for Monkeypox, with CEO Adar Poonawalla expressing optimism about its development within a year. The initiative follows the World Health Organization's declaration of Monkeypox as a global health emergency.
-
India's Serum Institute and Oxford University roll out first Malaria vaccine in Africa's Ivory Coast
Health | Jul 16, 2024, 04:10 PM ISTIndia's Serum Institute and Oxford University have launched the first malaria vaccine in Ivory Coast, Africa, marking a significant milestone in combating the deadly disease. This collaborative effort aims to save millions of lives in malaria-endemic regions.
-
Millions of COVID vaccines unsold; stopped production since Dec 2021: Poonawalla
India | Apr 23, 2022, 03:45 AM ISTOn the need for vaccinating kids in the 5-11 age bracket, he said, "My point is we can't put a price tag on the life of a person. Also if an additional dose of vaccine can prevent a 1,000 hospitalisation, so let's do that as was evident from the third wave."
-
Govt panel recommends Serum Institute's Covovax vaccine for 12-17 year olds
India | Apr 03, 2022, 09:20 PM ISTIndia's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12-17 age group, subject to certain conditions, on March 9.
-
CDSCO panel recommends emergency use authorisation for SII’s Covovax
India | Dec 28, 2021, 12:00 AM ISTA CDSCO panel has also recommended restricted emergency use of anti-Covid pill Molnupiravir in India.
-
Covovax not approved in country of origin yet, notes govt panel as it seeks data from SII
India | Nov 28, 2021, 12:27 PM ISTThe DCGI office had granted SII permission to manufacture and stock Covovax on May 17. Based on the DCGI's approval, till now, the Pune-based firm has manufactured and stockpiled vaccine doses.
-
Government allows Serum Institute to export 50 lakh Covishield doses under COVAX to 4 nations
India | Nov 21, 2021, 09:36 PM ISTThe government, earlier in October, had permitted the SII to export 10 lakh Covishield doses each to Nepal, Myanmar, and Bangladesh under the 'Vaccine Maitri' program.
-
Serum Institute seeks regular marketing authorisation from DCGI for Covishield
India | Oct 25, 2021, 09:51 PM ISTIf the DCGI grants regular marketing authorisation, Covishield will be the second vaccine in the world to receive such approval. Pfizer-BioNTech's COVID-19 vaccine has received full US FDA approval for use in individuals 16 years of age and older.
-
Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of USD 4.9 bn
Business | Sep 16, 2021, 11:02 PM ISTBiocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about USD 4.9 billion. Serum Institute Life Sciences (SILS) is a subsidiary of Serum Institute of India (SII).
-
Out of 65 crore Covid vaccine doses given so far, SII supplied over 60 cr Covishield doses: Sources
India | Aug 31, 2021, 09:48 PM ISTThe daily COVID-19 vaccinations crossed the 1 crore mark on Tuesday for the second time in five days, taking the total number of doses administered in the country to over 65 crore.
-
Recruitment of volunteers for trial of Covid vaccine Covovax on children begins
India | Aug 29, 2021, 08:00 PM ISTThe trial would be held across 10 sites and would cover 920 children -- 460 each in the age groups of 12-17 and 2-11 -- according to official sources.
-
SII chairman Poonawalla against using cocktail of COVID-19 vaccines
India | Aug 13, 2021, 06:25 PM ISTIf cocktail vaccines are administered and if the result is not good, then SII may say that another vaccine was not good, vice versa, the other company might say that since you mixed Serum's vaccine, it did not give desired results, Poonawalla said.
-
India pulled back global supply of COVAX due to surge of cases inside the country: USAID admin
World | Jul 16, 2021, 06:32 AM ISTThe shortage is going to end soon because the United States has purchased Pfizer’s vaccine which will start to come online in August, said USAID Administrator Samantha Power.
-
SII signs pact with RDIF to manufacture Sputnik V, production to begin in September
India | Jul 13, 2021, 02:05 PM ISTThe RDIF and Serum Institute of India, the world’s largest vaccine producer, will start production of Sputnik V vaccine in September.
-
Dip in average daily vaccination against COVID-19 since June 21: Govt data
India | Jul 12, 2021, 01:55 PM ISTA decline in average daily vaccination against the coronavirus has been seen since June 21, when the new phase of universalisation of COVID-19 vaccination commenced, government data showed.
-
Maharashtra: Covishield vaccine out of stock at Pune vaccination centres
India | Jul 05, 2021, 09:05 AM ISTThe Pune mayor on Sunday said that the Covishield will not be available at any vaccination centre under the jurisdiction of Pune Municipal Corporation today.
-
Over 1.45 crore vaccine doses available with states: Centre
India | Jun 26, 2021, 11:51 AM ISTMore than 1.45 crore COVID-19 vaccine doses are still available with states and union territories and over 19,10,650 jabs are in the pipeline.
-
Amid shortage complaints, Serum Institute promises 10 crore Covishield doses in June
India | May 30, 2021, 06:13 PM ISTSerum Institute of India (SII) has informed the government that it will be able to manufacture and supply nine to 10 crore doses of Covishield in June, official sources said on Sunday amid complaint by states about the shortage of anti-coronavirus vaccine jabs.
-
Global supply of COVAX hit due to coronavirus crisis in India, USAID tells lawmakers
World | May 28, 2021, 08:14 AM ISTThere are many parts of the world where one shot has been dispensed to health workers or frontline workers and the second shot has not been forthcoming, USAID told lawmakers on Thursday.
-
Dr VK Paul, member NITI Aayog, busts myths on vaccination process
News | May 27, 2021, 04:10 PM ISTMember (Health) in NiTi Aayog, Dr Vinod K Paul on Thursday addressed seven myths on India's Covid-19 vaccination program. He said these myths are arising due to distorted statements, half-truths, and blatant lies. India is in talk with Pfizer and Moderna for earliest import of vaccine.